← Regulatory news
Overseas가이던스2026. 6. 5.· FDA · openFDA

FDA CDRH 가이던스 2025~2026 발행 목록 (29건·원문 링크)

FDA CDRH가 2025년 이후 발행한 가이던스 29건을 발행일·원문 링크와 함께 정리.

미국 FDA 의료기기·방사선보건센터(CDRH)가 2025-01-01 이후 발행한 가이던스 29건(최종·초안 포함)을 발행일 순으로 정리했다. 제목의 링크는 FDA 원문으로 연결된다. 국내 RA 실무에 영향이 큰 항목은 별도 분석글에서 다룬다.

📌 29건 중 무엇부터 볼 것인가 REGNA 편집 해석

미국 진출을 준비한다면 이 목록에서 먼저 열 것은 다음 넷이다.

  • 인적요인(Human Factors) 최종 가이던스(2026-05-29) — 제출 유형이 위험도에 따라 3단계로 갈린다. 사용적합성 시험 계획을 언제 세우느냐가 일정 전체를 좌우한다.
  • 시판전신고 면제 의향(2026-06-05) — 미분류 기기 일부를 510(k) 면제로 돌리려는 문서다. 자사 품목이 대상이면 진입 비용이 크게 준다.
  • 임상의사결정지원(CDS) 소프트웨어 최종본(2026-01-29) — 소프트웨어가 «의료기기»에서 빠지는 경계를 다시 그었다. AI 기반 판독 보조를 만든다면 이 문서부터다.
  • 정형 임플란트용 환자맞춤 가이드(2026-05-07) — 3D 프린팅·맞춤형 제작을 하는 곳에 해당한다.

나머지는 품목별 510(k) 제출자료 권고가 대부분이다. 자사 품목명이 제목에 있는지로 걸러 읽으면 된다. 국내 실무 영향이 큰 항목은 별도 분석 기사에서 다룬다.

발행일구분제목(원문 링크)
06/05/2026 Final Intent to Exempt Certain Unclassified Medical Devices from Premarket Notification Requirements: Guidance for Industry and Food and Drug Administration Staff
05/29/2026 Final Content of Human Factors Information in Medical Device Marketing Submissions: Guidance for Industry and Food and Drug Administration Staff
05/07/2026 Final Patient-Matched Guides for Orthopedic Implants: Guidance for Industry and Food and Drug Administration Staff
04/20/2026 Draft Compliance Policy Regarding Premarket and Other Requirements for Certain NIOSH Approved Air-Purifying Respirators: Draft Guidance for Industry and Food and Drug Administration Staff
03/30/2026 Final Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle: Guidance for Industry, Food and Drug Administration Staff, and Other Interested Parties
03/13/2026 Final Medical Devices with Indications Associated with Weight Loss - Premarket Considerations: Guidance for Industry and Food and Drug Administration Staff
02/03/2026 Final Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions: Guidance for Industry and Food and Drug Administration Staff
02/03/2026 Final Computer Software Assurance for Production and Quality Management System Software: Guidance for Industry and Food and Drug Administration Staff
01/29/2026 Final Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff
01/23/2026 Draft Cuffless Non-invasive Blood Pressure Measuring Devices – Clinical Performance Testing and Evaluation: Draft Guidance for Industry and Food and Drug Administration Staff
01/06/2026 Final General Wellness: Policy for Low Risk Devices: Guidance for Industry and Food and Drug Administration Staff
12/18/2025 Final Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices: Guidance for Industry and Food and Drug Administration Staff
12/03/2025 Final eCopy Program for Medical Device Submissions: Guidance for Industry and Food and Drug Administration Staff
10/28/2025 Draft Menstrual Products - Performance Testing and Labeling Recommendations: Draft Guidance for Industry and Food and Drug Administration Staff
10/27/2025 Draft Quality Management System Information for Certain Premarket Submission Reviews: Draft Guidance for Industry and Food and Drug Administration Staff
09/23/2025 Final Consideration of Enforcement Policies for In Vitro Diagnostic Tests During a Section 564 Declared Emergency: Guidance for Industry and Food and Drug Administration Staff
08/22/2025 Final Animal Studies for Dental Bone Grafting Material Devices - Premarket Notification (510(k)) Submissions: Guidance for Industry and Food and Drug Administration Staff
08/18/2025 Final Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions: Guidance for Industry and Food and Drug Administration Staff
07/31/2025 Final Medical Device User Fee Small Business Qualification and Determination: Guidance for Industry, Food and Drug Administration Staff and Foreign Governments
06/06/2025 Draft Hernia Mesh – Package Labeling Recommendations: Draft Guidance for Industry and Food and Drug Administration Staff
06/05/2025 Draft Transfer of a Premarket Notification (510(k)) Clearance – Questions and Answers: Draft Guidance for Industry and Food and Drug Administration Staff
05/29/2025 Final Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program: - Final Guidance for Industry and Food and Drug Administration Staff
05/29/2025 Draft Electronic Submission Template for Medical Device Q-Submissions: Draft Guidance for Industry and Food and Drug Administration Staff
03/31/2025 Final Evaluation of Sex-Specific Data in Medical Device Clinical Studies - Guidance for Industry and Food and Drug Administration Staff
01/13/2025 Final Premarket Approval Application and Humanitarian Device Exemption Modular Review: Guidance for Industry and FDA Staff
01/07/2025 Final Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act: Guidance for Industry and Food and Drug Administration Staff
01/07/2025 Draft Pulse Oximeters for Medical Purposes - Non-Clinical and Clinical Performance Testing, Labeling, and Premarket Submission Recommendations: Draft Guidance for Industry and Food and Drug Administration S
01/07/2025 Draft Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations: Draft Guidance for Industry and Food and Drug Administration Staff
01/06/2025 Draft Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency: Draft Guidance for Industry and Food and Drug Administration Staff

출처: FDA CDRH Guidance Documents 데이터셋. 수집일 2026-06-11. 날짜는 FDA 표기(월/일/연) 원본.

Recent news on this topic

This tool is free. Why we started this · The data is built from MFDS notices and every result carries its source.

REGNA summarised and arranged this from the official original. It is for reference and has no legal force; check the original before any filing decision.